Mingdu Zhiyun
Latest round
- Series C
Last raised
- Feb 2024
Total raised
- $26M
Investors
- 8
About Mingdu Zhiyun
Established in 2017 and based in Zhejiang, China, Mingdu Zhiyun is a company that provides life cycle management solutions for the pharmaceutical industry. The company’s core members include technical experts such as Huawei and Alibaba, and pharmaceutical industry experts such as Thermo Fisher Scientific, NNIT, and Minsheng Pharmaceutical. In 2023, it acquired Zhimi. The company's products include drug registration and application system, drug R&D full life cycle management platform, drug manufacturing execution system, warehousing logistics system, etc. These platforms provide research and development, and pharmaceutical management services for pharmaceutical companies through the use of big data, algorithms, AI and other technologies. The company’s customers include Shanghai Pharmaceuticals Holding, LIVZON, China Resources Sanjiu Medical & Pharmaceutical, etc.
Who invested in Mingdu Zhiyun
8 investors across 3 rounds
See all investors in Mingdu Zhiyun
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mingdu Zhiyun
Who invested in Mingdu Zhiyun?
Mingdu Zhiyun has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mingdu Zhiyun raised?
Mingdu Zhiyun has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Mingdu Zhiyun last raise money?
Mingdu Zhiyun's most recent round on record is a Series C, in Feb 2024.
What does Mingdu Zhiyun do?
Established in 2017 and based in Zhejiang, China, Mingdu Zhiyun is a company that provides life cycle management solutions for the pharmaceutical industry.
Where is Mingdu Zhiyun headquartered?
Mingdu Zhiyun is headquartered in Hangzhou, China.
Which VCs invest in companies like Mingdu Zhiyun?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Mingdu Zhiyun's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Mingdu Zhiyun? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.